numient
amneal pharma europe ltd - levodopa, carbidopa - parkinsons sygdom - anti-parkinson-lægemidler - symptomatisk behandling af voksne patienter med parkinsons sygdom.
carbidopa/levodopa "orion" 25+100 mg tabletter
orion corporation - carbidopamonohydrat, levodopa - tabletter - 25+100 mg
levodopa/carbidopa "teva" 200+50 mg depottabletter
teva b.v. - carbidopamonohydrat, levodopa - depottabletter - 200+50 mg
sinemet 50 + 12,5 mg tabletter
2care4 aps - carbidopa, levodopa - tabletter - 50 + 12,5 mg
sinemet plus 25+100 mg tabletter
2care4 aps - carbidopa, levodopa - tabletter - 25+100 mg
sinemet depot mite 25+100 mg depottabletter
n.v. organon - carbidopa, levodopa - depottabletter - 25+100 mg
sinemet 12,5/50 12,5+50 mg tabletter
n.v. organon - carbidopa, levodopa - tabletter - 12,5+50 mg
duodopa 20+5 mg/ml enteralgel
abbvie a/s - carbidopa, levodopa - enteralgel - 20+5 mg/ml
inbrija
acorda therapeutics ireland limited - levodopa - parkinsons sygdom - anti-parkinson-lægemidler - inbrija er angivet for den intermitterende behandling af episodisk motoriske fluktuationer (off episoder) hos voksne patienter med parkinsons sygdom (pd) behandles med levodopa/dopa-decarboxylase inhibitor.
carbidopa/levodopa "orifarm" 12,5+50 mg tabletter
orifarm healthcare a/s - carbidopamonohydrat, levodopa - tabletter - 12,5+50 mg